Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Lee, Se-Hoon

Class:IdPerson:8853022
_displayNameLee, Se-Hoon
_timestamp2016-01-21 20:36:26
created[InstanceEdit:8853004] Rothfels, Karen, 2016-01-21
firstnameSe-Hoon
initialSH
surnameLee
(author)[LiteratureReference:8853002] The transcriptional landscape and mutational profile of lung adenocarcinoma
[LiteratureReference:9665365] Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2
[LiteratureReference:9713384] Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer
[LiteratureReference:9713886] Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor
[LiteratureReference:9713909] Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer
[Change default viewing format]
No pathways have been reviewed or authored by Lee, Se-Hoon (8853022)